{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:08:18Z","timestamp":1774310898011,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203774"],"award-info":[{"award-number":["82203774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.1038\/s41388-026-03720-0","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:54:36Z","timestamp":1772769276000},"page":"1187-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-Jun-activated S100A10 promotes malignant progression via in diminishing ubiquitin-dependent degradation of vimentin in gastric cancer"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6749-5499","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-he","family":"Sikong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-dan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"3720_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"3720_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11864-020-00774-4","volume":"21","author":"TH Patel","year":"2020","unstructured":"Patel TH, Cecchini M. Targeted Therapies in Advanced Gastric Cancer. Curr Treat Opt Oncol. 2020;21:70.","journal-title":"Curr Treat Opt Oncol"},{"key":"3720_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun. 2023;43:525\u201361.","journal-title":"Cancer Commun"},{"key":"3720_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.18097\/PBMC20156105579","volume":"61","author":"OV Kurmyshkina","year":"2015","unstructured":"Kurmyshkina OV, Belova LL, Kovchur PI, Volkova TO. [Remodeling of angiogenesis and lymphangiogenesis in cervical cancer development]. Biomed Khim. 2015;61:579\u201397.","journal-title":"Biomed Khim"},{"key":"3720_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1055\/a-2085-3964","volume":"55","author":"M Simonnot","year":"2023","unstructured":"Simonnot M, Deprez PH, Pioche M, Albuisson E, Wallenhorst T, Caillol F, et al. Endoscopic resection of early esophageal tumors in patients with cirrhosis or portal hypertension: a multicenter observational study. Endoscopy. 2023;55:785\u201395.","journal-title":"Endoscopy"},{"key":"3720_CR6","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.32604\/or.2025.060440","volume":"33","author":"GZ Xu","year":"2025","unstructured":"Xu GZ, Guan HY, Guo YG, Zhang YR, Pan JH, Luo S, et al. USP13 Suppresses Colorectal Cancer Angiogenesis by Downregulating VEGFA Expression through Inhibition of the PTEN-AKT Pathway. Oncol Res. 2025;33:1947\u201367.","journal-title":"Oncol Res"},{"key":"3720_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ebiom.2019.01.057","volume":"41","author":"D Izumi","year":"2019","unstructured":"Izumi D, Gao F, Toden S, Sonohara F, Kanda M, Ishimoto T, et al. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer. EBioMedicine. 2019;41:268\u201375.","journal-title":"EBioMedicine"},{"key":"3720_CR8","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1038\/s41388-020-01610-7","volume":"40","author":"RR Ma","year":"2021","unstructured":"Ma RR, Zhang H, Chen HF, Zhang GH, Tian YR, Gao P. MiR-19a\/miR-96-mediated low expression of KIF26A suppresses metastasis by regulating FAK pathway in gastric cancer. Oncogene. 2021;40:2524\u201338.","journal-title":"Oncogene"},{"key":"3720_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7150\/jca.36203","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Ma Y, Fei F, Zheng M, Li Z, Zhao Q, et al. Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases. J Cancer. 2020;11:826\u201336.","journal-title":"J Cancer"},{"key":"3720_CR10","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/1878-0261.12356","volume":"12","author":"M Bydoun","year":"2018","unstructured":"Bydoun M, Sterea A, Liptay H, Uzans A, Huang WY, Rodrigues GJ, et al. S100A10, a novel biomarker in pancreatic ductal adenocarcinoma. Mol Oncol. 2018;12:1895\u2013916.","journal-title":"Mol Oncol"},{"key":"3720_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0592-3","volume":"12","author":"L Wang","year":"2019","unstructured":"Wang L, Yan W, Li X, Liu Z, Tian T, Chen T, et al. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin. J Ovarian Res. 2019;12:113.","journal-title":"J Ovarian Res"},{"key":"3720_CR12","doi-asserted-by":"publisher","first-page":"559486","DOI":"10.3389\/fcell.2020.559486","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Li XY, Li LX, Zhou RC, Sikong Y, Gu X, et al. S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer. Front Cell Dev Biol. 2020;8:559486.","journal-title":"Front Cell Dev Biol"},{"key":"3720_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000078","volume":"42","author":"AE Patteson","year":"2020","unstructured":"Patteson AE, Vahabikashi A, Goldman RD, Janmey PA. Mechanical and Non-Mechanical Functions of Filamentous and Non-Filamentous Vimentin. Bioessays. 2020;42:e2000078. p.","journal-title":"Bioessays"},{"key":"3720_CR14","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3390\/cancers13194985","volume":"13","author":"S Usman","year":"2021","unstructured":"Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh MT, et al. Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers (Basel). 2021;13:4985.","journal-title":"Cancers (Basel)"},{"key":"3720_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-024-03043-6","volume":"43","author":"H Li","year":"2024","unstructured":"Li H, Zhu YZ, Xu L, Han T, Luan J, Li X, et al. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer. J Exp Clin Cancer Res. 2024;43:129.","journal-title":"J Exp Clin Cancer Res"},{"key":"3720_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.prp.2018.07.014","volume":"214","author":"S Yin","year":"2018","unstructured":"Yin S, Chen FF, Yang GF. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis. Pathol Res Pract. 2018;214:1376\u201380.","journal-title":"Pathol Res Pract"},{"key":"3720_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00109-018-1720-z","volume":"97","author":"H Zhang","year":"2019","unstructured":"Zhang H, Wu X, Xiao Y, Wu L, Peng Y, Tang W, et al. Coexpression of FOXK1 and vimentin promotes EMT, migration, and invasion in gastric cancer cells. J Mol Med. 2019;97:163\u201376.","journal-title":"J Mol Med"},{"key":"3720_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04401-2","volume":"21","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Feng Y, Huang J, Huang Z, Tan R, Li T, et al. LAD1 promotes malignant progression by diminishing ubiquitin-dependent degradation of vimentin in gastric cancer. J Transl Med. 2023;21:632.","journal-title":"J Transl Med"},{"key":"3720_CR19","doi-asserted-by":"publisher","first-page":"48725","DOI":"10.18632\/oncotarget.10706","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Zhang Y, Sui Z, Zhang Y, Liu M, Tang H. USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells. Oncotarget. 2017;8:48725\u201336.","journal-title":"Oncotarget"},{"key":"3720_CR20","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.clbc.2019.08.010","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Wang YW, Chen X, Ma RR, Guo XY, Liu HT, et al. MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT. Clin Breast Cancer. 2020;20:e113\u2013e26.","journal-title":"Clin Breast Cancer"},{"key":"3720_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V. Epithelial Mesenchymal Transition in Tumor Metastasis. Annu Rev Pathol. 2018;13:395\u2013412.","journal-title":"Annu Rev Pathol"},{"key":"3720_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molcel.2016.09.014","volume":"64","author":"F Ohtake","year":"2016","unstructured":"Ohtake F, Saeki Y, Ishido S, Kanno J, Tanaka K. The K48-K63 Branched Ubiquitin Chain Regulates NF-\u03baB Signaling. Mol Cell. 2016;64:251\u201366.","journal-title":"Mol Cell"},{"key":"3720_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jpha.2023.08.006","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Gao X, Zheng Y, Yang Y, Gao J, Geng D, et al. Hydralazine represses Fpn ubiquitination to rescue injured neurons via competitive binding to UBA52. J Pharm Anal. 2024;14:86\u201399.","journal-title":"J Pharm Anal"},{"key":"3720_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnci\/djh148","volume":"96","author":"J Folkman","year":"2004","unstructured":"Folkman J. Angiogenesis and c-Jun. J Natl Cancer Inst. 2004;96:644.","journal-title":"J Natl Cancer Inst"},{"key":"3720_CR25","first-page":"618","volume":"25","author":"E Tsiambas","year":"2020","unstructured":"Tsiambas E, Mastronikolis N, P Fotiades P, Kyrodimos E, Chrysovergis A, Papanikolaou V, et al. c-Jun\/c-Fos complex in laryngeal squamous cell carcinoma. J buon. 2020;25:618\u201320.","journal-title":"J buon"},{"key":"3720_CR26","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68:3033\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"3720_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10555-023-10154-7","volume":"43","author":"A Tabatabaee","year":"2024","unstructured":"Tabatabaee A, Nafari B, Farhang A, Hariri A, Khosravi A, Zarrabi A, et al. Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance. Cancer Metastasis Rev. 2024;43:363\u201377.","journal-title":"Cancer Metastasis Rev"},{"key":"3720_CR28","first-page":"1235","volume":"25","author":"S Otsuki","year":"2011","unstructured":"Otsuki S, Inokuchi M, Enjoji M, Ishikawa T, Takagi Y, Kato K, et al. Vimentin expression is associated with decreased survival in gastric cancer. Oncol Rep. 2011;25:1235\u201342.","journal-title":"Oncol Rep"},{"key":"3720_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05552-2","volume":"14","author":"W Shao","year":"2023","unstructured":"Shao W, Li J, Piao Q, Yao X, Li M, Wang S, et al. FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion. Cell Death Dis. 2023;14:13.","journal-title":"Cell Death Dis"},{"key":"3720_CR30","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.3390\/cells11233770","volume":"11","author":"S Tiwari","year":"2022","unstructured":"Tiwari S, Singh A, Gupta P, Singh S. UBA52 Is Crucial in HSP90 Ubiquitylation and Neurodegenerative Signaling during Early Phase of Parkinsonas Disease. Cells. 2022;11:3770.","journal-title":"Cells"},{"key":"3720_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep36780","volume":"6","author":"M Kobayashi","year":"2016","unstructured":"Kobayashi M, Oshima S, Maeyashiki C, Nibe Y, Otsubo K, Matsuzawa Y, et al. The ubiquitin hybrid gene UBA52 regulates ubiquitination of ribosome and sustains embryonic development. Sci Rep. 2016;6:36780.","journal-title":"Sci Rep"},{"key":"3720_CR32","doi-asserted-by":"crossref","unstructured":"Mao J, O\u2019Gorman C, Sutovsky M, Zigo M, Wells KD, Sutovsky P. Ubiquitin A-52 residue ribosomal protein fusion product 1 (Uba52) is essential for preimplantation embryo development. Biol Open. 2018;7(10):bio035717.","DOI":"10.1242\/bio.035717"},{"key":"3720_CR33","doi-asserted-by":"publisher","first-page":"e18164","DOI":"10.1111\/jcmm.18164","volume":"28","author":"L Tong","year":"2024","unstructured":"Tong L, Zheng X, Wang T, Gu W, Shen T, Yuan W, et al. Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression. J Cell Mol Med. 2024;28:e18164.","journal-title":"J Cell Mol Med"},{"key":"3720_CR34","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/cas.13951","volume":"110","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Hou Z, Zuo S, Zhou X, Feng Y, Sun Y, et al. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Cancer Sci. 2019;110:1194\u2013207.","journal-title":"Cancer Sci"},{"key":"3720_CR35","first-page":"7166","volume":"11","author":"F Wang","year":"2019","unstructured":"Wang F, Chen X, Yu X, Lin Q. Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells. Am J Transl Res. 2019;11:7166\u201385.","journal-title":"Am J Transl Res"},{"key":"3720_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07804-9","volume":"16","author":"B Zhang","year":"2025","unstructured":"Zhang B, Lu S, Xiao X, Xu Y, Zhang S, Chen L, et al. Targeting the ROCK2\/UBA52\/DRP1 axis enhances ferroptosis and overcomes pemigatinib resistance in Cholangiocarcinoma. Cell Death Dis. 2025;16:493.","journal-title":"Cell Death Dis"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03720-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:12:52Z","timestamp":1774307572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03720-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,4,14]]}},"alternative-id":["3720"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03720-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethical Committee on Scientific Research of Shandong University Qilu Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}